QT
AUPH icon

Quantbot Technologies’s Aurinia Pharmaceuticals AUPH Stock Holding History

Quantbot Technologies’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-20,500
Closed -$103K – 1426
2024
Q1 		$103K Buy
+20,500
New +$139K 0.01% 1164
2022
Q4 		– Sell
-29,600
Closed -$222K – 1664
2022
Q3 		$222K Buy
+29,600
New +$256K 0.02% 848
2017
Q2 		– Sell
-37,554
Closed -$275K – 1100
2017
Q1 		$275K Buy
+37,554
New +$173K 0.03% 556

Other funds holding AUPH

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Quantbot Technologies's AUPH Position: Q2 2024 in Review

Quantbot Technologies sold out of Aurinia Pharmaceuticals (AUPH) in Q2 2024, closing a stake of 20,500 shares — an estimated $103K sold.

Quantbot Technologies first reported a position in AUPH in Q1 2017 and held it in 3 quarters. The position peaked at $275K in Q1 2017. 171 funds tracked by Wall St. Rank hold AUPH as of Q2 2024.

  • Quantbot Technologies reported no remaining Aurinia Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Quantbot Technologies sold 20,500 Aurinia Pharmaceuticals shares in Q2 2024, an estimated $103K.
  • Quantbot Technologies first reported a position in Aurinia Pharmaceuticals in Q1 2017 and held it in 3 quarters.
  • Quantbot Technologies's Aurinia Pharmaceuticals position peaked at $275K in Q1 2017.
  • 171 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2024.

Based on Quantbot Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.